SCHEMBL958698

SCHEMBL958698

Clc1cccc(Oc2ccccc2Cl)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
HTT P42858 1/20 0.53
MAP4K4 O95819 1/20 0.51
IDO1 P14902 1/20 0.48
KMT2A Q03164 2/20 0.45
GRM4 Q14833 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.41
BLM P54132 1/20 0.40
HPGD P15428 1/20 0.40
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CXCL8 P10145 1/20 0.38
PIM1 P11309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10697201 0.85 L3MBTL1 (0.41) ALDH1A1HTTMAP4K4IDO1KMT2A
SCHEMBL9493242 0.82 L3MBTL1 (0.42) ALDH1A1HTTMAP4K4IDO1GRM4
SCHEMBL10547159 0.81 ALDH1A1 (0.50) ALDH1A1HTTMAP4K4IDO1KMT2A
SCHEMBL30350822 0.81 MAP4K4 (0.49) ALDH1A1HTTMAP4K4KMT2AL3MBTL1
SCHEMBL10547151 0.81 ALDH1A1 (0.50) ALDH1A1HTTMAP4K4IDO1KMT2A
SCHEMBL19510981 0.81 MAP4K4 (0.49) ALDH1A1HTTMAP4K4KMT2AL3MBTL1
SCHEMBL958410 0.80 MAPT (0.47) ALDH1A1HTTGRM4L3MBTL1HPGD
SCHEMBL960152 0.80 RHEB (0.44) ALDH1A1HTTMAP4K4KMT2AGRM4
SCHEMBL1122090 0.78 ALDH1A1 (0.58) ALDH1A1HTTMAP4K4IDO1KMT2A
SCHEMBL29090763 0.78 MAP4K4 (0.52) MAP4K4L3MBTL1KDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
EP-2253618-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING GPR4, NR3C2, NR5A2 ALDH1A1 2384/4885HTT 2718/4885MAP4K4 2519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.